From Cancer Good Things Grow – A Survivor’s Story|Grace Gawler Interviews Jeffrey Deslandes

Jeffrey Deslandes thought he had it all. The father of five children, he had his whole life ahead of him. But on one fateful day in 1999, he believed it was all over when he was diagnosed with an aggressive form of cancer. He was wrong. His life had just begun!

from cancer good things growA true story of survival: Share the good news. Listen to Navigating the Cancer Maze: From Cancer Good Things Grow.  If you know someone with lymphoma, leukaemia, melanoma or other cancers – you need to tell them about Jeffrey Deslandes and how he survived and thrive thanks to cancer vaccines. They need to read his story.

Jeffrey Deslandes thought he had it all. The father of five children, he had his whole life ahead of him. But on one fateful day in 1999, he believed it was all over when he was diagnosed with an aggressive form of cancer. He was wrong. His life had just begun!

His diagnosis, B cell non-Hodgkin’s lymphoma, follicular mixed small and large cell, Stage IV, with bcl-2 gene translocation, with spleen and bone marrow involvement. His prognosis; poor.

His is an inspiring, positive, and true story about surviving cancer—and the things it teaches you. You grow as a person. You learn what is really important in life. You discover who your true friends are. Listen to my interview with Jeffrey on Voice America’s Health & Wellness Channel – Navigating the Cancer Maze: From Cancer Good Things Grow.  (Note: The show is sponsored by the Grace Gawler Institute. Free to listen – live stream on demand – select link above or download and listen another time – share with friends and fellow patients. Live broadcast 12 noon Friday – USA time(PST) – Australia – 6 am Qld time.

After traditional treatments, such as chemotherapy, failed to control his cancer, Jeffrey started looking for emerging therapies. When he learned of an experimental treatment involving a personalised vaccine protocol, he pursued it. It is now feasible to have something good—a personalised cancer vaccine—created from something bad—your cancer. This one-of-a-kind vaccine reeducated his immune system so that it could identify and destroy his cancer.

Jeffrey’s story is not a gloom-and-doom tale of yet another poor soul enduring cancer treatment. Instead, he shares his story in the hope of reaching and inspiring other cancer patients who may have given up. Some of the stories in this book come from his deep spiritual core, but he is not a “religious” man. He doesn’t require you to believe these stories, only to know that everything detailed in this book is true.

See Press pass info – share this link to others.

ABOUT Jeffrey Deslandes: Jeffrey is a native of Melbourne, Australia. He has a Masters in Engineering Science, and is a Doctor of Philosophy, attained at the University of Melbourne. He has been married twice and has five children.  His is an inspiring, positive, and true story about surviving cancer—and the things it teaches you. You grow as a person. You learn what is really important in life. Compelled to write about his experience. “From Cancer Good Things Grow” was published recently. Available as ebook and soft cover.(Balboa Press) BUY online at: Balboa Press:

All proceeds from the sale of this book go directly to cancer vaccine research in Brisbane where Jeffrey had his treatment. He wants more people to know about his doctor and the the hope that vaccines bring for recovery. For more information about Jeffrey’s treatment – please contact me via the contact page on this BLOG or via www.gracegawlerinstitute.com

Note: Dendritic cell vaccines are highly technical and need rigorous quality control and expertise. Ask me for further information on how to access this treatment.

VOICE AMERICA LINK to listen to audio:

http://www.voiceamerica.com/episode/82217/from-cancer-good-things-grow-a-survivors-story

Until next time…… Grace

An Answer to Cancer – How Your Immune Body-Clock can assist Complete Remission Grace Gawler with Martin Ashdown

Could timing of cancer treatments be the missing link in delivery of cancer therapies? Sounds too simple to be true? Two cancer researchers Martin Ashdown & Brendon Coventry are “immunological explorers” who not only unearthed a buried “treasure”; but they have also created a map for other innovative cancer “explorers” to follow. The “treasure” is a cancer drug used for more than 20 years that is now providing oncologists with new information about how to best help patients achieve complete remission. The drug called interleukin-2, is providing cancer researchers with something akin to how the “Rosetta Stone” was used to unlock historical script; the outcome; mapping the immune cycle!

An Answer to Cancer – How Your Immune Body-Clock can assist Complete Remission

Be sure to mark this coming weekend in your diary (7,8 November) to listen to this inspiring and significant edition of Navigating the Cancer Maze.

The Cancer Immune Cycle - A Window of Opportunity in Treatment Efficacy
The Cancer Immune Cycle – A Window of Opportunity in Treatment Efficacy

The show can be downloaded on itunes or reached at any time live streaming at the link below.
http://www.voiceamerica.com/episode/81479/an-answer-to-cancer-how-your-immune-body-clock-can-assist-complete-remission

The show is broadcast by Voice America on internet radio – but is distributed world wide and is a must for all cancer patients. Please select link at bottom of page to be directed to the eCard for this weeks edition. You can also sign up with Voice America to receive notice of ongoing shows. You can also sign up and follow this blog ( in the right side bar)  to receive weekly invaluable cancer information and Navigating the Cancer Maze links direct to your email inbox.

We know you will be inspired and encouraged by this show – so we have a call to action page on our website where cancer patients can be involved.

To join or read about the Cancer Immune Cycle Registry
please visit: http://www.gracegawlerinstitute.com/immune-cycle-registry/

 

This week……..An Answer to Cancer – How Your Immune Body-Clock can assist Complete Remission

Could timing of cancer treatments be the missing link in delivery of cancer therapies? Sounds too simple to be true? Two cancer researchers Martin Ashdown & Brendon Coventry are “immunological explorers” who not only unearthed a buried “treasure”; but they have also created a map for other innovative cancer “explorers” to follow. The “treasure” is a cancer drug used for more than 20 years that is now providing oncologists with new information about how to best help patients achieve complete remission. The drug called interleukin-2, is providing cancer researchers with something akin to how the “Rosetta Stone” was used to unlock historical script; the outcome; mapping the immune cycle! Join me with guest Martin Ashdown on Navigating the Cancer Maze to hear the story of this amazing breakthrough. Learn how you can access info about your immune cycle to assist cancer treatment efficacy.            Please Remember to like us on Facebook!

TROUBLE VIEWING?
Click Here to view the Promo card on the web

SIGN-UP NOW!
Click to become a VoiceAmerica Member for Free!

 

Navigating the Immune System | The Key to Future Cancer Therapies

Today on Voice America’s Navigating the Cancer Maze, I interview Professor Mark Smyth who is regarded as an international leader in tumour immunology, immunotherapy and natural killer (NK) cell biology. My co-host is Dr Bruce Whelan, GP.We are nk-cells-(green)-attack-diseased-human-cellsaware there is a great need for cancer education in the community. By understanding the intricacies of the immune system in parallel with the biological nature of cancer; we believe that patients will make better informed decisions regarding their choice of cancer treatment.

Prof Mark Smyth and Dr Bruce Whelan GP
Prof Mark Smyth and Dr Bruce Whelan GP

 

Today on Voice America’s Navigating the Cancer Maze, I interview Professor Mark Smyth who is regarded as an international leader in tumour immunology, immunotherapy and natural killer (NK) cell biology. My co-host is Dr Bruce Whelan, GP.

Episode Description

Today I interview Professor Mark Smyth who is regarded as an international leader in tumour immunology, immunotherapy and natural killer (NK) cell biology. My co-host is Dr Bruce Whelan, GP. Dr Whelan and I see cancer patients in our practices.

We are aware there is a great need for cancer education in the community. By understanding the intricacies of the immune system in parallel with the biological nature of cancer; we believe that patients will make better informed decisions regarding their choice of cancer treatmentProfessor Smyth is a person of influence who has made key discoveries in his field.

A number of those discoveries have led to new clinical trials in cancer immunotherapy. Professor Smyth relocated to the QIMR nk-cells-(green)-attack-diseased-human-cellsBerghofer in Brisbane (2013) as Senior Scientist and NH&MRC Australia Fellow.

He is a Senior Editor at Cancer Research, & a member of the Scientific Advisory Board of the Cancer Research Institute (USA).

Learn More:  www.qimrberghofer.edu.au

Professor Mark Smyth

Professor Mark Smyth  received his PhD from the University of Melbourne in 1988 & trained at the National Cancer Institute (USA) 1988-1992.

After 8 years at Austin Research Institute Melbourne, working on mechanisms of lymphocyte-mediated cytotoxicity, he relocated to Peter Macallum where his studies on effector molecules collectively rekindled world-wide interest in cancer immune surveillance. A number of his discoveries have led to new clinical trials in cancer immunotherapy.

Professor Smyth relocated to QIMR Berghofer, Brisbane (2013) as a Senior Scientist and NH&MRC Australia Fellow. He is a Senior Editor at Cancer Research, and a member of the Scientific Advisory Board of the Cancer Research Institute (USA).

Summary

The Immunology in Cancer and Infection Laboratory currently focuses upon advancing our understanding of the basic principles underlying an immune response to cancer and infection.

A Natural Killer cell (yellow) attacks a cancer cell. The NK cell reaches out and delivers the “kiss of death.”
A Natural Killer cell (yellow) attacks a cancer cell.
The NK cell reaches out and delivers the “kiss of death.”

 We aim to further understand these processes at the molecular level, with particular emphasis on the role of the innate immune system, in particular, NK cells, NKT cells and gamma-delta T cells.

Our laboratory is building a detailed picture of how networks of immune cells function to recognise, respond to, and destroy tumour cell masses and metastases. We are interested in defining the importance, timing, and nature of the natural immune response to transformation.

We are also using new antigens (including glycolipids), antibodies, and cytokines in combination to stimulate strong innate and lasting adaptive immunity to cancer.

Our findings are being used to develop more effective biological and cellular therapies for human cancer, in particular, melanoma, breast and prostate cancer, and haematological cancers.

Learn more about Prof Smyth’s research

at http://www.qimrberghofer.edu.au/page/Lab/Immunology_Cancer_Infection

 

One of QIMR Berghofer’s three Research Programs is cancer, one of the major causes of illness and death in Australia and the developed world.   In 2012, it is estimated that more than 120,700 Australians were diagnosed with cancer (excluding non-melanoma skin cancer). Cancer accounted for about 3 in 10 deaths in Australia, making it the second most common cause of death, exceeded only by cardiovascular diseases. Cancer is a disease which is caused by abnormal cell growth and eventually spreads to other parts of the body. Some cancers are common within a family history and are clearly inherited, while others are caused by factors in the environment interacting with genetic susceptibilities. Many forms of cancer can be treated successfully if detected early.

Cancer types researched by QIMR Berghofer Medical Research Institute

  • Blood cancers (including leukaemia, lymphoma and myelomas)
  • Brain cancer (glioblastoma)
  • Breast cancer
  • Colorectal (bowel) cancer
  • Endometrial cancer
  • Lung cancer
  • Melanoma
  • Multiple endocrine neoplasia type 1 (endocrine cancer)
  • Nasopharyngeal carcinoma (nose and throat cancer)
  • Non-melanoma skin cancer (actinic solar keratosis, squamous cell carcinoma, basal cell carcinoma)
  • Oesophageal cancer (including Barrett’s oesophagus)
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Stomach (gastric) cancer

Learn More:  www.qimrberghofer.edu.au Navigating the Cancer Maze is presented by the Grace Gawler Institute for Integrated Cancer Solutions, Gold Coast Australia. We are a not for profit health promotion charity.

How our immune System Fights Cancer|Knowledge to Help you Navigate the Cancer Maze Grace Gawler & Prof Jerome Galon

Do want to get some insights into the intricate working of your immune system? Navigating the Cancer Maze, Grace Gawler interviews Prof. Dr. Jerome Galon: Research Director at INSERM (National Institute of Health and Medical Research) & leader of the INSERM Integrative Cancer Immunology laboratory, at the Cordeliers Research Centre, Paris, France.

Do want to get some insights into the intricate working of your immune system and cancer? On Navigating the Cancer Maze, internet radio Grace Gawler interviews Prof. Dr. Jerome Galon: Research Director at INSERM (National Institute of Health and Medical Research) & leader of the INSERM Integrative Cancer Immunology laboratory, at the Cordeliers Research Centre, Paris, France.

PROF DR. JEROME GALON
PROF DR. JEROME GALON

Listen to the show by selecting the following link:

http://www.voiceamerica.com/episode/78656/how-our-immune-system-fights-cancer-knowledge-to-help-you-navigate-the-cancer-maze

 

Professor Galon’s current interests & major contributions concern basic & translational research in cancer immunology, using systems biology.

His laboratory has made some ground-breaking findings demonstrating that the adaptive immune response within a tumor was a better predictor of survival than traditional staging based on the size and spread of a tumor.The new wave of immunotherapies reflects what has been known for some time; that the answer to cancer is in you! But it is not that simple. Our immune system is complex and intricate & as science unravels its mysteries, we are developing new understandings of how the immune system can be captured & recruited in the laboratory; retrained and returned to you the patient!

Awards: In 2008 Prof Dr Galon was awarded The Colon Cancer Research Schaeverbeke Award, Fondation de France,& the Clinical Research Award, Rose Lamarca, Fondation pour la Recherche Médicale.

INSERM UMRS1138  Laboratory of Integrative Cancer Immunology (Team 15) Cordeliers Research Center 15 Rue de l'Ecole de Medecine 75006 Paris, France
INSERM
Laboratory of Prof Jerome Galon Integrative Cancer Immunology (Team 15)
Cordeliers Research Center

In 2010 he received the William B. Coley Award from the Cancer Research Institute, NY, USA, 2011: the French National Academy of Science & the French National Academy of Medicine (2011) awards.

He has published many scientific papers and book chapters.


Health professionals and interested patients;

Visit INSERM UMRS 1138
Cordeliers Research Center
 at http://www.ici.upmc.fr/

For more about Integrative Cancer Immunology Laboratory and their research projects, Immunoscore, publications, seminars and links.

Health professionals – I especially recommend the Publications page and homepage side bar at INSERM’s website.

Prof Galon was a guest of QIMR Berghofer Medical Research Institute, Brisbane Qld , Australia. See their website at http://www.qimrberghofer.edu.au/

To listen to the audio – live streaming log on to the URL below. You can download this and other interviews with cancer experts at:

http://www.voiceamerica.com/episode/78656/how-our-immune-system-fights-cancer-knowledge-to-help-you-navigate-the-cancer-maze

To be continued……..

Enjoy the weekend….Grace

How Your Body Can Fight Cancer – Immunotherapies are on their way Grace Gawler with Professor Rajiv Khanna

How Your Body Can Fight Cancer – Immunotherapies are on their way! QIMR Brisbane is celebrating their cancer research findings by hosting a series of immunology presentations during Immunotherapy Week, June 15 – June 21 2014. Special Guest speaker will be Professor Jérôme Galon, Cordelier Research Center, Paris, France whose topic is “Cancer cure may be inside you and unleashed by immunotherapy”. To bring public awareness to Immunotherapy Week at the QIMR Berghofer Medical Research Institute, Brisbane Professor Rajiv Khanna Director of immunotherapy and vaccine development was interviewed on Navigating the Cancer Maze radio this week to publicize the need to bring research findings and medical trials into public awareness.

How Your Body Can Fight Cancer – Immunotherapies are on their way!

QIMR Brisbane is celebrating their cancer research findings by hosting a series of immunology presentations during Immunotherapy Week, June 15 – June 21 2014. Special Guest speaker will be Professor Jérôme Galon, Cordelier Research Center, Paris, France whose topic is “Cancer cure may be inside you and unleashed by immunotherapy”.

907477-rajiv-khannaTo bring public awareness to Immunotherapy Week at the QIMR Berghofer Medical Research Institute, Brisbane Professor Rajiv Khanna Director of immunotherapy and vaccine development was interviewed on Navigating the Cancer Maze radio this week to publicize the need to bring research findings and medical trials into public awareness. In particular he discusses his breakthrough immunotherapy research on Glioblastoma Multiforme.

As well on Navigating the Cancer Maze, Prof Khanna also discusses his research and clinical trial results on nasopharyngeal carcinoma, an aggressive throat cancer that has has shown response to immune therapies.

Image: Above – Cancer researcher Professor Rajiv Khanna, pictured with patient Eddie Chen, has developed a promising new treatment. Picture: Annette Dew Source: The Courier-Mail.

CLICK HERE to read Janelle Miles Courier Mail article – ‘Queensland Institute of Medical Research scientist Rajiv Khanna unveils promising new treatment for aggressive throat cancer’  published FEBRUARY 02, 2012

To listen to this very interesting and highly informative audio interview or to download on itunes (both free of charge), visit the link below direct to voice America and my show webpage.

http://www.voiceamerica.com/episode/78495/navigating-the-brain-cancer-maze-promising-results-from-world-first-brain-cancer-trials

Grace Gawler NAVIGATING THE CANCER MAZE eCard

Promising Results from World-First Brain Cancer Trials Professor Rajiv Khanna | Grace Gawler on Navigating The Cancer Maze

It is imperative that breakthroughs in cancer treatments are known to the world. Worldwide, there are an estimated 240,000 cases of brain and nervous system tumors diagnosed each year; GBM is the most common, and the most lethal of these tumors. People speak of the War on Cancer, but it is our bodies that are at war with cancer cells via our immune system and its responses. Utilizing the immune system principle, scientists at the QIMR Berghofer Medical Research Institute, Australia, have used immunotherapy to create a major breakthrough in the treatment of the brain cancer known as Glioblastoma Multiforme (GBM).

Free informational cancer seminars Brisbane June 15 – 21 2014 Brisbane.

Click the link below to see other events presented by QIMR – for immunology week June 15 – 21 2014 Brisbane.

How your body can fight cancer Seminars

cancer-lambert_2469736bPromising Results from World-First Brain Cancer Trials Professor Rajiv Khanna Joins Grace Gawler on Navigating The Cancer Maze To Talk about a Brain Cancer breakthrough.

Phoenix, AZ — 06/13/2014 — Voice America Talk Radio Network, Internet broadcasting pioneer, producing and syndicating online audio and video, today announced that Professor Rajiv Khanna QIMR Berghofer Medical Research Institute Australia will join Grace Gawler host of Navigating the Cancer Maze program on the VoiceAmerica Health and Wellness Channel (http://www.voiceamerica.com/show/2125/navigating-the-cancer-maze) Friday, June 13, 2014 at 12 noon Pacific Time.

NOTE: show goes live to air 5 am Brisbane Australia time Saturday 14 June 2014. Available streaming audio any time after 9 am this Saturday and available to download on itunes indefinitely.

It is imperative that breakthroughs in cancer treatments are known to the world. Worldwide, there are an estimated 240,000 cases of brain and nervous system tumors diagnosed each year; GBM is the most common, and the most lethal of these tumors. People speak of the War on Cancer, but it is our bodies that are at war with cancer cells via our immune system and its responses.  Utilizing the immune system principle, scientists at the QIMR Berghofer Medical Research Institute, Australia, have used immunotherapy to create a major breakthrough in the treatment of the brain cancer known as Glioblastoma Multiforme (GBM). Study leader, Professor Rajiv Khanna, said most of the study participants lived much longer than the six-month prognosis normally given to a patient with recurrent GBM, and some patients showed no signs of disease progression. “It is early days, but this is exciting,” Professor Khanna said.

“Survival rates for this aggressive cancer have barely changed in decades. There is an urgent clinical need for new treatments. “If this treatment can buy patients more time, then that is a big step forward.”

GBM
Image of Brain GBM

GBM is the most common malignant brain cancer, diagnosed in about 800 Australians every year.  Despite surgery, radiotherapy and chemotherapy, less than 10% of patients survive beyond five years. This study built on previous research which found that many brain tumours carry cytomegalovirus (CMV). About half of all Australians have the virus, but usually show no symptoms.

Professor Khanna developed a technique to modify the patients’ T-cells in the laboratory, effectively “train” them to attack the virus, and then return them to the patient’s body.  When the killer T-cells destroyed the virus, they also destroyed the cancer. “It’s becoming increasingly clear that immunotherapy – manipulating a person’s own immune system – is a rich new frontier for cancer treatment,” Professor Khanna said.

The QIMR is celebrating their research findings by hosting a series of immunology and cancer presentations between June 15 and June 21 in Brisbane. For those people who cannot attend, watch out on the websites for more information. www.qimrberghofer.edu.au   or  www.gracegawlermedia.com

The Phase I trials were conducted at Brisbane’s Wesley Hospital, under the leadership of neurosurgeon Professor David Walker.  “Working with patients with malignant brain tumors can be distressing, because we know so many will succumb,” Professor Walker said. “But this new branch of therapy lets us offer some hope that the future is going to be brighter, that new and innovative treatments mean things will hopefully improve in the future. “We have a long way to go, and there is hard work to be done, but we seem to be on the right track, and it is a pleasure to work with scientists at QIMR Berghofer to try to make a real difference.”

The research team is now keen to begin the next phase of trials, involving patients at an earlier stage of the cancer’s development. “These would be patients who have just been diagnosed and are about to start the standard treatments – surgery, then radiotherapy or chemotherapy.  We would generate the T cell therapy before their standard treatment, and then administer T cells in conjunction with the standard therapy,” Professor Khanna said.

“We hope that the treatment can be even more effective if given at an earlier stage of the disease.”

This study is published online in the prestigious US journal Cancer Research and can be viewed at http://cancerres.aacrjournals.org/content/early/recent

The research was funded by Flagship Funding from the Rio Tinto Ride to Conquer Cancer, the NHMRC and private donors.

The QIMR Berghofer Medical Research Institute is a world leading translational research institute focused on cancer, infectious diseases, mental health and a range of complex diseases. Working in close collaboration with clinicians and other research institutes, our aim is to improve health by developing new diagnostics, better treatments and prevention strategies.

For more information about QIMR Berghofer Visit: www.qimrberghofer.edu.au

Immunology and Cancer Survival | Navigating the Cancer Maze| Grace Gawler

QIMR Berghofer Medical Research Institute is hosting Immunotherapy week: Get updated about Immunotherapies. Next week QIMR presents a series of lectures about the latest developments in Cancer Immune therapies. QIMR’s Professor Khanna, has been researching immunotherapies and has had a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM).

ATTENTION Queenslanders interested in immune-based Cancer Therapies:  Cancer Immunotherapy Week Brisbane

QIMR Berghofer Medical Research Institute is hosting Immunotherapy week: Get updated about Immunotherapies. Next week QIMR presents a series of lectures about the latest developments in Cancer Immune therapies.

Scientists at the QIMR Berghofer Medical Research Institute have used immunotherapy to make a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM). There will be a presentation on Tuesday evening and other presentations throughout the week.

CLICK HERE FOR MORE INFORMATION

QIMR IMMUNOTHERAPY WEEK
Later this week on Navigating the Cancer Maze I will be interviewing…Professor Rajiv Khanna a leading researcher at The QIMR Berghofer Medical Research Institute, Brisbane, Australia; a world progressive translational research institute focused on cancer, infectious diseases, mental health and a range of complex diseases. Professor Khanna has been researching immunotherapies and has had a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM). Professor Khanna developed a technique to modify the patients’ T-cells in the laboratory, effectively “train” them to attack the virus, and then return them to the patient’s body.  When the killer T-cells destroyed the virus, they also destroyed the cancer. “It’s becoming increasingly clear that immunotherapy – manipulating a person’s own immune system – is a rich new frontier for cancer treatment,” Professor Khanna said. Be informed about the answer to cancer. Support Immunotherapy week- Brisbane Qld. More info at http://www.qimrberghofer.edu.au/

All shows are available in the content Library at Navigating the Cancer Maze on The VoiceAmerica Variety Channel for on-demand and pod cast download. The Grace Gawler Institute is a not for profit health promotion charity providing global access to free information for cancer patients about the latest in cancer information and treatments from experts, patients, caregivers and researchers.

Visit:  http://www.gracegawlerinstitute.com

Navigating the Cancer Maze | i am the answer to cancer |Cancer Immunotherapy Month

Navigating the Cancer Maze | i am the answer to cancer |Cancer Immunotherapy Month. Where is the answer to cancer? According to Jill O’Donnell-Tormey, Ph.D and the organization she represents,Cancer Research Institute (CRI); the answer is ‘i am the answer to cancer’; yes-the patients immune system holds the answer to cancer!

Navigating the Cancer Maze | i am the answer to cancer |Cancer Immunotherapy Month
June 6, 2014
Did you know that June is Cancer Immunotherapy Month? Tune in to Navigating the Cancer Maze for inspiring listening and learn about the good news – the Answer to Cancer
Dr. Jill O'Donnell-Tormey PhD CEO Cancer Research Institute NY
Dr. Jill O’Donnell-Tormey PhD CEO Cancer Research Institute NY

Where is the answer to cancer? According to my guest Jill O’Donnell-Tormey, Ph.D and the organization she represents,Cancer Research Institute (CRI); the answer is ‘i am the answer to cancer’; yes-the patients immune system holds the answer to cancer! Select link below to listen to audio

http://www.voiceamerica.com/episode/78363/navigating-the-cancer-maze-i-am-the-answer-to-cancer-cancer-immunotherapy-month

The CRI is a non-profit organization founded in 1953 & today’s global leader in supporting & coordinating research aimed at harnessing the immune system’s power to conquer all cancers. Jill will explain immunotherapy & its value to cancer patients as well as the different types of cancer immunotherapy available. There will be patient stories & an exploration of the very latest in immunotherapy. A New Cancer Immunotherapy Website for Patients and Caregivers was launched recently. Get on board with supporters like Olivia Newton John who recently lent public support to CRI.   http://www.cancerresearch.org         http://www.TheAnswerToCancer.org

Listen to Navigating the Cancer Maze 12 Noon Fridays – live from Arizona (PST) – Saturday Australia 5am free to air or download and listen later – available free download on itunes.

READ MORE:

http://www.sbwire.com/press-releases/dr-jill-odonnell-tormey-phd-ceo-director-of-scientific-affairs-of-the-cancer-research-institute-ny-joins-grace-gawler-on-navigating-the-cancer-maze-to-talk-about-cancer-immunotherapy-month-516331.htm

LISTEN TO INTERVIEW:

http://www.voiceamerica.com/episode/78363/navigating-the-cancer-maze-i-am-the-answer-to-cancer-cancer-immunotherapy-month

Please remember to Like us facebook & spread the good news about the Answer to Cancer!

CIM-homepage-slider_Cancer-Immunotherapy-Month_960x395-JUNE

Why We Need to Search for the Truth in Cancer Cure Stories – Ovarian Cancer Help Part 3

Last week on Navigating the Cancer Maze on Voice America Health and Wellness Channel, I mentioned a immune treatment that is being acclaimed as a value add therapy for many cancer patients – in particular, those dealing with ovarian Cancer…

 Last week on Navigating the Cancer Maze on Voice America Health and Wellness Channel, I mentioned a immune treatment that is being acclaimed as a value add therapy for many cancer patients – in particular, those dealing with ovarian Cancer…

The links and information follows:DENVAXTM – DENDRITIC CELL THERAPY – Customized Cell-based Cancer Immunotherapy INSTITUTE OF CELLULAR THERAPIES ( source )

ovarian cancer
Ovarian Cancer – Dendritic cell vaccine shows promise

Ovarian cancer: A 58 yr old lady was diagnosed of cancer ovary in June 2004. Her CA 125 antigen marker was positive and in the range of 10,000 units. She was operated upon and given six cycles of chemotherapy. She recovered from her disease and her marker was also within normal range.  After one year, the CA 125 began rising and she presented to us with an increased titre of 400 units. There were signs of recurrence, and she opted for DC (DENVAX) therapy in June 2005. She has completed three years of receiving DENVAX. She is free of disease, proven both clinically and by radiological examinations. Her CA 125 marker is also stable for the last three years.

http://www.dendriticcellresearch.com/success_stories
http://www.dendriticcellresearch.com/publications

CUSTOMIZED DENDRITIC CELL IMMUNOTHERAPY IN CANCER

Another treatment greatly assisting Ovarian cancer patients is used by Hallwang Private Oncology Clinic in Germany. Removab – a trifunctional antibody has been used at the Clinic for many years Click Here for information


Last week I also discussed
a new book by controversial American Cancer Physician Dr David Agus. His latest book A Short Guide to a Long Life by David B. Agus, MD, is published by Simon & Schuster ($24.99) and available on Amazon.

In his #1 New York Times bestselling book, The End of Illness, Dr. David B. Agus shared what he has learned from his work as a pioneering cancer doctor and researcher, revealing the innovative steps he takes to prolong the lives of not only cancer patients but all those hoping to enjoy a vigorous, lengthy life.

Now Dr. Agus has turned his analysis into a practical and concise illus­trated handbook for everyday living. He believes optimal health begins with our daily habits.

In A Short Guide to a Long Life, David Agus espouses the idea that prolonged good health starts with lots of smallish changes today. Much of the advice – don’t skip breakfast; avoid sunburn – will be familiar. He notes that Hippocrates made many of the same observations – “Walking is man’s best friend”; “Let food be thy medicine and medicine be thy food” – in the 4th century BC. Yet the truth is that few of us have so far incorporated them into our lives.

Some of Agus’s rules are cute: for instance, “Smile – the act itself will trigger the release of pain-killing, brain-happy endorphins and serotonin.” Others seem quirky – he’s adamantly against high heels: they cause inflammation, which can raise your lifetime risk of heart attack, strokes and cancer, he says.
A few of his dictums will give pause for uncomfortable thought. Rule 56 says to avoid airport backscatter X-ray scanners. Until science can prove they’re safe, Agus says, “I’ll be requesting the manual pat-down massage when I go through airports. You should, too.”
He debunks fads: rule 60 is “No Juicing”. “Does the body really like consuming 10 carrots all at once? Or a pound of radishes? I think not.” Or how about “Eat real food”. That means avoiding anything in a packet. It doesn’t matter if it announces itself to be good for you somehow by being, say, “cholesterol free” or “antioxidant rich”. “If they have to tell you why you should be eating it, you shouldn’t be eating it.”
In the book, Agus’s voice is calm and reassuring. In person, it’s more urgent. At one point he asks me if I’ve had a flu shot this year. I haven’t. “You should get it now,” he says. “If you get the flu, in a decade from now your chance of cancer or heart disease is elevated … So go and get that flu shot if you want to play with those grandkids. It’s a sore arm.”
Like most cancer doctors he sees the advanced disease; what can’t be reversed.   He wants to instil a new way of thinking about cancer. It’s not something that visits us from outside, he says. We don’t “get” cancer. Rather, we need to stop our bodies from “cancering”. Cancer is a verb, not a noun.
Some rules for living longer – A Short Guide to a Long Life by David B. Agus, MD

Caffeine, especially from traditional sources, may have protective, anti-cancer properties. But moderation is key.
Smiling triggers the release of pain-killing, brain-happy endorphins and serotonin.
Uncomfortable shoes cause inflammation that can have an impact on your entire system … Inflammation has been linked to heart disease, Alzheimer’s, cancer, autoimmune diseases and diabetes.
– Track your movement during the day with an accelerometer, and develop a daily personal activity target. Being sedentary is about as bad for you as smoking.
Cleanliness counts. Wash your hands regularly, especially after exposure to germy things such as bathrooms.
To reap the benefits of exercise, including all those biochemical reactions that lower your risk of illness, aim to break a sweat and get your heart pumping fast for a minimum of 15 minutes a day.
Moderate alcohol intake, especially from red wine, can reduce one’s risk of heart disease. This benefit does have a caveat: drinking can potentially increase one’s risk for breast cancer, and drinking too much is far worse for your heart than being a teetotaller. Agus has a glass of red a day.
Cold-water fish, such as salmon, sardines, tuna, trout, anchovies, herring, halibut, cod, black cod, mackerel and mahi-mahi are excellent sources of high-quality protein, healthy fats and naturally occurring vitamins and minerals.
A daily low-dose aspirin (75mg) has been shown to reduce the risk of developing common malignant cancers in the lungs, colon and prostate by 46 per cent. So if you’re basking in the glory of middle age, this is something to discuss with your doctor. It’s the cheapest fountain of youth around and requires no prescription.  Read the article about Dr David Agus in the Australian Good Weekend Magazine

 Voice America Grace Gawler